192 related articles for article (PubMed ID: 24904842)
1. The role of eicosanoids in experimental Lyme arthritis.
Pratt CL; Brown CR
Front Cell Infect Microbiol; 2014; 4():69. PubMed ID: 24904842
[TBL] [Abstract][Full Text] [Related]
2. Borrelia burgdorferi infection induces lipid mediator production during Lyme arthritis.
Brown CR; Dennis EA
Biochimie; 2017 Oct; 141():86-90. PubMed ID: 28630010
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-146a provides feedback regulation of lyme arthritis but not carditis during infection with Borrelia burgdorferi.
Lochhead RB; Ma Y; Zachary JF; Baltimore D; Zhao JL; Weis JH; O'Connell RM; Weis JJ
PLoS Pathog; 2014 Jun; 10(6):e1004212. PubMed ID: 24967703
[TBL] [Abstract][Full Text] [Related]
4. 5-Lipoxygenase-deficient mice infected with Borrelia burgdorferi develop persistent arthritis.
Blaho VA; Zhang Y; Hughes-Hanks JM; Brown CR
J Immunol; 2011 Mar; 186(5):3076-84. PubMed ID: 21270404
[TBL] [Abstract][Full Text] [Related]
5. Follistatin-like protein 1 is a critical mediator of experimental Lyme arthritis and the humoral response to Borrelia burgdorferi infection.
Campfield BT; Nolder CL; Marinov A; Bushnell D; Davis A; Spychala C; Hirsch R; Nowalk AJ
Microb Pathog; 2014 Aug; 73():70-9. PubMed ID: 24768929
[TBL] [Abstract][Full Text] [Related]
6. Dual role for Fcγ receptors in host defense and disease in Borrelia burgdorferi-infected mice.
Belperron AA; Liu N; Booth CJ; Bockenstedt LK
Front Cell Infect Microbiol; 2014; 4():75. PubMed ID: 24967215
[TBL] [Abstract][Full Text] [Related]
7. Significant differences between the Borrelia-infection and Borrelia-vaccination and -infection models of Lyme arthritis in C3H/HeN mice.
Nardelli DT; Luedtke JO; Munson EL; Warner TF; Callister SM; Schell RF
FEMS Immunol Med Microbiol; 2010 Oct; 60(1):78-89. PubMed ID: 20662925
[TBL] [Abstract][Full Text] [Related]
8. Different patterns of expression and of IL-10 modulation of inflammatory mediators from macrophages of Lyme disease-resistant and -susceptible mice.
Gautam A; Dixit S; Embers M; Gautam R; Philipp MT; Singh SR; Morici L; Dennis VA
PLoS One; 2012; 7(9):e43860. PubMed ID: 23024745
[TBL] [Abstract][Full Text] [Related]
9. T-Helper 17 Cell Cytokine Responses in Lyme Disease Correlate With Borrelia burgdorferi Antibodies During Early Infection and With Autoantibodies Late in the Illness in Patients With Antibiotic-Refractory Lyme Arthritis.
Strle K; Sulka KB; Pianta A; Crowley JT; Arvikar SL; Anselmo A; Sadreyev R; Steere AC
Clin Infect Dis; 2017 Apr; 64(7):930-938. PubMed ID: 28077518
[TBL] [Abstract][Full Text] [Related]
10. Age-Related Differential Stimulation of Immune Response by
Djokic V; Primus S; Akoolo L; Chakraborti M; Parveen N
Front Immunol; 2018; 9():2891. PubMed ID: 30619263
[TBL] [Abstract][Full Text] [Related]
11. Treatment of
Hilliard KA; Brown CR
J Immunol; 2019 Mar; 202(6):1798-1806. PubMed ID: 30700583
[TBL] [Abstract][Full Text] [Related]
12. A murine model of Lyme disease demonstrates that Borrelia burgdorferi colonizes the dura mater and induces inflammation in the central nervous system.
Casselli T; Divan A; Vomhof-DeKrey EE; Tourand Y; Pecoraro HL; Brissette CA
PLoS Pathog; 2021 Feb; 17(2):e1009256. PubMed ID: 33524035
[TBL] [Abstract][Full Text] [Related]
13. The DBA/1 strain is a novel mouse model for experimental Borrelia burgdorferi infection.
Campfield BT; Nolder CL; Davis A; Hirsch R; Nowalk AJ
Clin Vaccine Immunol; 2012 Oct; 19(10):1567-73. PubMed ID: 22855391
[TBL] [Abstract][Full Text] [Related]
14. Lyme arthritis: linking infection, inflammation and autoimmunity.
Lochhead RB; Strle K; Arvikar SL; Weis JJ; Steere AC
Nat Rev Rheumatol; 2021 Aug; 17(8):449-461. PubMed ID: 34226730
[TBL] [Abstract][Full Text] [Related]
15. Hamster and murine models of severe destructive Lyme arthritis.
Munson E; Nardelli DT; Du Chateau BK; Callister SM; Schell RF
Clin Dev Immunol; 2012; 2012():504215. PubMed ID: 22461836
[TBL] [Abstract][Full Text] [Related]
16. Forward genetic approaches for elucidation of novel regulators of Lyme arthritis severity.
Bramwell KK; Teuscher C; Weis JJ
Front Cell Infect Microbiol; 2014; 4():76. PubMed ID: 24926442
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-10 (IL-10) inhibits Borrelia burgdorferi-induced IL-17 production and attenuates IL-17-mediated Lyme arthritis.
Hansen ES; Medić V; Kuo J; Warner TF; Schell RF; Nardelli DT
Infect Immun; 2013 Dec; 81(12):4421-30. PubMed ID: 24042116
[TBL] [Abstract][Full Text] [Related]
18. Infectious arthritis and immune dysregulation: lessons from Lyme disease.
Iliopoulou BP; Huber BT
Curr Opin Rheumatol; 2010 Jul; 22(4):451-5. PubMed ID: 20375899
[TBL] [Abstract][Full Text] [Related]
19. Lipidomic analysis of dynamic eicosanoid responses during the induction and resolution of Lyme arthritis.
Blaho VA; Buczynski MW; Brown CR; Dennis EA
J Biol Chem; 2009 Aug; 284(32):21599-612. PubMed ID: 19487688
[TBL] [Abstract][Full Text] [Related]
20.
Jutras BL; Lochhead RB; Kloos ZA; Biboy J; Strle K; Booth CJ; Govers SK; Gray J; Schumann P; Vollmer W; Bockenstedt LK; Steere AC; Jacobs-Wagner C
Proc Natl Acad Sci U S A; 2019 Jul; 116(27):13498-13507. PubMed ID: 31209025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
